{"id":298533,"date":"2026-10-09T13:10:11","date_gmt":"2026-10-09T07:40:11","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=298533"},"modified":"2026-10-09T13:10:11","modified_gmt":"2026-10-09T07:40:11","slug":"global-health-share-price-prediction-2027","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/global-health-share-price-prediction-2027\/","title":{"rendered":"Global Health Share Price Prediction 2027: Scenario Targets, Valuation and Technical Outlook"},"content":{"rendered":"<p style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:10px 16px;font-style:italic;\"><em>CMP Rs 1,295.30 (9 Oct 2026). 52W range Rs 956.00 to Rs 1,544.00. PE 62.13. 2027 base Rs 1,554, bull Rs 1,636.<\/em><\/p>\n<div style=\"background:#F0F9FF;border-left:4px solid #2E7D32;border-radius:6px;padding:14px 18px;margin:18px 0;\">\n<p style=\"margin:0;color:#1F4E79;font-size:14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin:8px 0 0;\">The Global Health share price forecast for 2027 centres on a conservative case of Rs 1,490, a base case of Rs 1,554 and a bull case of Rs 1,636, against a current price of Rs 1,295.30. These targets scale today&#8217;s price by reported EPS growth at a constant PE multiple, so they rest on earnings the company has already delivered, not on broker forecasts. The base case implies 20.0% upside from today&#8217;s price. The daily technical setup reads bearish.<\/p>\n<\/p><\/div>\n<p>Global Health share price prediction 2027 comes down to earnings growth and the multiple investors pay for it, and the reported numbers give a measured answer. The stock trades at Rs 1,295.30 on NSE as of 9 October 2026, 16.1% below its 52-week high of Rs 1,544.00, after the company reported net profit of Rs 554.07 crore for FY26.<\/p>\n<p>This Global Health stock forecast 2027 builds conservative, base and bull scenarios from exchange-reported financials, shareholding data and daily price indicators, with every assumption shown.<\/p>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&#038;utm_medium=share-price-prediction-2027\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/global-health-share-price-prediction-2027\/#Global_Health_Share_Price_Today_and_Key_Data\" title=\"Global Health Share Price Today and Key Data\">Global Health Share Price Today and Key Data<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/global-health-share-price-prediction-2027\/#What_Is_the_Global_Health_Share_Price_Prediction_for_2027\" title=\"What Is the Global Health Share Price Prediction for 2027?\">What Is the Global Health Share Price Prediction for 2027?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/global-health-share-price-prediction-2027\/#Global_Health_Share_Price_Forecast_What_Has_to_Go_Right_by_2027\" title=\"Global Health Share Price Forecast: What Has to Go Right by 2027\">Global Health Share Price Forecast: What Has to Go Right by 2027<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/global-health-share-price-prediction-2027\/#Conservative_Case_for_the_Global_Health_Share_Price_Target_Rs_1490\" title=\"Conservative Case for the Global Health Share Price Target: Rs 1,490\">Conservative Case for the Global Health Share Price Target: Rs 1,490<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/global-health-share-price-prediction-2027\/#Base_Case_for_the_Global_Health_Share_Price_Target_Rs_1554\" title=\"Base Case for the Global Health Share Price Target: Rs 1,554\">Base Case for the Global Health Share Price Target: Rs 1,554<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/global-health-share-price-prediction-2027\/#Bull_Case_for_the_Global_Health_Share_Price_Target_Rs_1636\" title=\"Bull Case for the Global Health Share Price Target: Rs 1,636\">Bull Case for the Global Health Share Price Target: Rs 1,636<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/global-health-share-price-prediction-2027\/#Global_Health_Financial_Performance_Revenue_Profit_and_Margins\" title=\"Global Health Financial Performance: Revenue, Profit and Margins\">Global Health Financial Performance: Revenue, Profit and Margins<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/global-health-share-price-prediction-2027\/#Is_Global_Health_Overvalued_or_Undervalued_Right_Now\" title=\"Is Global Health Overvalued or Undervalued Right Now?\">Is Global Health Overvalued or Undervalued Right Now?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/global-health-share-price-prediction-2027\/#Global_Health_Stock_Analysis_Technical_Outlook\" title=\"Global Health Stock Analysis: Technical Outlook\">Global Health Stock Analysis: Technical Outlook<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/global-health-share-price-prediction-2027\/#Global_Health_Shareholding_Pattern\" title=\"Global Health Shareholding Pattern\">Global Health Shareholding Pattern<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/global-health-share-price-prediction-2027\/#Key_Risks_to_the_Global_Health_Share_Price_Target_for_2027\" title=\"Key Risks to the Global Health Share Price Target for 2027\">Key Risks to the Global Health Share Price Target for 2027<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/global-health-share-price-prediction-2027\/#Earnings_and_Margin_Risk\" title=\"Earnings and Margin Risk\">Earnings and Margin Risk<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/global-health-share-price-prediction-2027\/#Size_and_Liquidity_Risk\" title=\"Size and Liquidity Risk\">Size and Liquidity Risk<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/global-health-share-price-prediction-2027\/#Balance_Sheet_Risk\" title=\"Balance Sheet Risk\">Balance Sheet Risk<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/global-health-share-price-prediction-2027\/#Technical_Risk\" title=\"Technical Risk\">Technical Risk<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/global-health-share-price-prediction-2027\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/global-health-share-price-prediction-2027\/#Frequently_Asked_Questions_on_Global_Health_Share_Price_Prediction_2027\" title=\"Frequently Asked Questions on Global Health Share Price Prediction 2027\">Frequently Asked Questions on Global Health Share Price Prediction 2027<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/global-health-share-price-prediction-2027\/#What_is_the_Global_Health_share_price_target_for_2027\" title=\"What is the Global Health share price target for 2027?\">What is the Global Health share price target for 2027?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/global-health-share-price-prediction-2027\/#What_is_the_Global_Health_share_price_today\" title=\"What is the Global Health share price today?\">What is the Global Health share price today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-20\" href=\"https:\/\/univest.in\/blogs-2\/global-health-share-price-prediction-2027\/#Is_Global_Health_a_good_stock_to_buy_for_2027\" title=\"Is Global Health a good stock to buy for 2027?\">Is Global Health a good stock to buy for 2027?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-21\" href=\"https:\/\/univest.in\/blogs-2\/global-health-share-price-prediction-2027\/#Can_Global_Health_stock_reach_Rs_1636_in_2027\" title=\"Can Global Health stock reach Rs 1,636 in 2027?\">Can Global Health stock reach Rs 1,636 in 2027?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-22\" href=\"https:\/\/univest.in\/blogs-2\/global-health-share-price-prediction-2027\/#What_are_the_support_and_resistance_levels_for_Global_Health\" title=\"What are the support and resistance levels for Global Health?\">What are the support and resistance levels for Global Health?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-23\" href=\"https:\/\/univest.in\/blogs-2\/global-health-share-price-prediction-2027\/#What_are_the_main_risks_for_Global_Health_stock_in_2027\" title=\"What are the main risks for Global Health stock in 2027?\">What are the main risks for Global Health stock in 2027?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-24\" href=\"https:\/\/univest.in\/blogs-2\/global-health-share-price-prediction-2027\/#How_is_the_Global_Health_target_price_for_2027_calculated\" title=\"How is the Global Health target price for 2027 calculated?\">How is the Global Health target price for 2027 calculated?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Global_Health_Share_Price_Today_and_Key_Data\"><\/span><strong>Global Health Share Price Today and Key Data<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The Global Health share price today is Rs 1,295.30 on NSE, up 1.47% on the day. The market capitalisation stands at Rs 34,310 crore. Over the past year the price has fallen 5.8% from Rs 1,374.50. Every Global Health stock forecast figure below starts from this price.<\/p>\n<table style=\"border-collapse:collapse;width:100%;margin:16px 0;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #cccccc;padding:8px;text-align:left;background:#F2F2F2;\">Metric<\/th>\n<th style=\"border:1px solid #cccccc;padding:8px;text-align:left;background:#F2F2F2;\">Value<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Company<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Global Health (MEDANTA)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Current Price<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Rs 1,295.30<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">52-Week High<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Rs 1,544.00 (27 August 2026)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">52-Week Low<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Rs 956.00 (30 March 2026)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Market Cap<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Rs 34,310 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">PE Ratio<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">62.13<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Industry PE<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">62.79<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">PB Ratio<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">8.66<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">EPS (TTM)<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Rs 20.54<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Return on Equity<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">14.05%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Debt to Equity<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">0.30<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Dividend Yield<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">0.04%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Book Value per Share<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Rs 147.34<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"What_Is_the_Global_Health_Share_Price_Prediction_for_2027\"><\/span><strong>What Is the Global Health Share Price Prediction for 2027?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The Global Health share price prediction for 2027 is a conservative case of Rs 1,490, a base case of Rs 1,554 and a bull case of Rs 1,636. Against Rs 1,295.30, these imply 15.0% upside, 20.0% upside and 26.3% upside. They are model scenarios built from reported EPS growth, not broker targets.<\/p>\n<table style=\"border-collapse:collapse;width:100%;margin:16px 0;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #cccccc;padding:8px;text-align:left;background:#F2F2F2;\">Scenario<\/th>\n<th style=\"border:1px solid #cccccc;padding:8px;text-align:left;background:#F2F2F2;\">EPS Growth Basis<\/th>\n<th style=\"border:1px solid #cccccc;padding:8px;text-align:left;background:#F2F2F2;\">EPS Estimate<\/th>\n<th style=\"border:1px solid #cccccc;padding:8px;text-align:left;background:#F2F2F2;\">PE Multiple<\/th>\n<th style=\"border:1px solid #cccccc;padding:8px;text-align:left;background:#F2F2F2;\">Implied Value<\/th>\n<th style=\"border:1px solid #cccccc;padding:8px;text-align:left;background:#F2F2F2;\">Upside vs Current Price<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Conservative Case<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Lower of FY26 growth (15.3%) and 4-year CAGR (27.7%) (capped at 15%)<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Rs 23.62 (+15.0%)<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Unchanged from today (price to EPS ratio kept constant)<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Rs 1,490<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">+15.0%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Base Case<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Average of the two (capped at 20%)<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Rs 24.65 (+20.0%)<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Unchanged from today (price to EPS ratio kept constant)<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Rs 1,554<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">+20.0%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Bull Case<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Higher of the two (capped at 25%)<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Rs 25.67 (+25.0%)<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Re-rated 1.1% toward industry PE of 62.79 (still at or below it)<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Rs 1,636<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">+26.3%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Each target takes today&#8217;s price of Rs 1,295.30 and scales it by the EPS growth assumed for that case, which is the same as holding the PE multiple constant. The conservative case uses the lower of the FY26 EPS growth and the 4-year EPS CAGR, the base case uses their average and the bull case uses the higher figure. The bull case also re-rates the PE multiple toward the industry level, because the stock trades below it. Together they form the Global Health target price range for the FY27 outlook over the next 12 months, and the range is not a point estimate.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Global_Health_Share_Price_Forecast_What_Has_to_Go_Right_by_2027\"><\/span><strong>Global Health Share Price Forecast: What Has to Go Right by 2027<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Each Global Health target price below depends on a specific EPS outcome, and the text states that outcome next to the number.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Conservative_Case_for_the_Global_Health_Share_Price_Target_Rs_1490\"><\/span><strong>Conservative Case for the Global Health Share Price Target: Rs 1,490<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Reaching Rs 1,490 needs EPS to rise 15.0% to Rs 23.62 while the stock keeps its current PE multiple. That follows the slower 4-year EPS CAGR of 27.7%.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Base_Case_for_the_Global_Health_Share_Price_Target_Rs_1554\"><\/span><strong>Base Case for the Global Health Share Price Target: Rs 1,554<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Reaching Rs 1,554 needs EPS to rise 20.0% to Rs 24.65, the average of the FY26 growth rate and the 4-year CAGR. Net profit growth of -1.1% in Q1 FY27 is below that pace, so earnings need to speed up to reach this level.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Bull_Case_for_the_Global_Health_Share_Price_Target_Rs_1636\"><\/span><strong>Bull Case for the Global Health Share Price Target: Rs 1,636<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Reaching Rs 1,636 needs EPS to rise 25.0% to Rs 25.67 and the PE multiple to re-rate 1.1% toward the industry PE. That is above the 52-week high of Rs 1,544.00, so it would need a fresh breakout. A daily close above the nearest resistance level of Rs 1,298.60 (200-day EMA) would be the first technical confirmation.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Global_Health_Financial_Performance_Revenue_Profit_and_Margins\"><\/span><strong>Global Health Financial Performance: Revenue, Profit and Margins<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Global Health earned net profit of Rs 554.07 crore on revenue of Rs 4,508.86 crore in FY26, with profit up 15.1% and revenue up 19.6% compared with FY25. Diluted EPS was Rs 20.66 against Rs 17.92 a year earlier, and that earnings base anchors the Global Health share price forecast.<\/p>\n<table style=\"border-collapse:collapse;width:100%;margin:16px 0;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #cccccc;padding:8px;text-align:left;background:#F2F2F2;\">Year<\/th>\n<th style=\"border:1px solid #cccccc;padding:8px;text-align:left;background:#F2F2F2;\">Revenue (Rs Cr)<\/th>\n<th style=\"border:1px solid #cccccc;padding:8px;text-align:left;background:#F2F2F2;\">Net Profit (Rs Cr)<\/th>\n<th style=\"border:1px solid #cccccc;padding:8px;text-align:left;background:#F2F2F2;\">EPS (Rs)<\/th>\n<th style=\"border:1px solid #cccccc;padding:8px;text-align:left;background:#F2F2F2;\">Operating Margin<\/th>\n<th style=\"border:1px solid #cccccc;padding:8px;text-align:left;background:#F2F2F2;\">Net Margin<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">FY22<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">2,205.82<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">196.20<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">7.77<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">22.91%<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">8.89%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">FY23<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">2,759.16<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">326.08<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">12.57<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">25.30%<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">11.82%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">FY24<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">3,349.78<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">478.06<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">17.80<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">26.98%<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">14.27%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">FY25<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">3,771.29<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">481.32<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">17.92<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">24.79%<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">12.76%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">FY26<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">4,508.86<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">554.07<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">20.66<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">23.30%<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">12.29%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>In the latest reported quarter, Q1 FY27 (quarter ended June 2026), revenue was Rs 1,326.21 crore against Rs 1,051.30 crore a year earlier (+26.1%), and the bottom line was a net profit of Rs 157.25 crore against a net profit of Rs 158.98 crore (-1.1%). Operating margin was 23.69% versus 25.90% in the year-ago quarter. Cash flow from operations was Rs 714.39 crore in FY26 against Rs 623.76 crore in FY25. Together these figures set the earnings base for the Global Health share price prediction.<\/p>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/screeners\"><strong>Check the Univest Screener for live Global Health fundamentals<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Is_Global_Health_Overvalued_or_Undervalued_Right_Now\"><\/span><strong>Is Global Health Overvalued or Undervalued Right Now?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Global Health trades at a PE of 62.13 against an industry PE of 62.79, which places the stock in line with the industry average. The price-to-book ratio is 8.66 on a book value of Rs 147.34 per share. Return on equity of 14.05% means the company earns Rs 14.05 of profit for every Rs 100 of shareholder equity.<\/p>\n<p>Debt to equity is 0.30, so borrowings equal about 30% of shareholder equity. The company declared a dividend of Rs 0.50 per share for FY26, a yield of 0.04% at the current price. This valuation context frames the Global Health stock price prediction for 2027 without relying on any outside forecast.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Global_Health_Stock_Analysis_Technical_Outlook\"><\/span><strong>Global Health Stock Analysis: Technical Outlook<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Global Health stock trades below its 50-day SMA of Rs 1,426.33 and below its 200-day EMA of Rs 1,298.60, and the combined daily indicators read bearish. The 52-week high of Rs 1,544.00 was set on 27 August 2026, while the 52-week low of Rs 956.00 came on 30 March 2026.<\/p>\n<table style=\"border-collapse:collapse;width:100%;margin:16px 0;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #cccccc;padding:8px;text-align:left;background:#F2F2F2;\">Indicator<\/th>\n<th style=\"border:1px solid #cccccc;padding:8px;text-align:left;background:#F2F2F2;\">Reading<\/th>\n<th style=\"border:1px solid #cccccc;padding:8px;text-align:left;background:#F2F2F2;\">Signal<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">RSI (14)<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">15.63<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Oversold<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">MACD (12,26,9)<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">-38.24 vs signal -17.83<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Bearish<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">ADX (14)<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">27.88<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Established trend<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Supertrend (10,3)<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Price below Rs 1,425.10<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Bearish<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">50-day SMA<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Rs 1,426.33<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Price below<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">200-day EMA<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Rs 1,298.60<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Price below<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>The nearest support level sits at Rs 956.00 (52-week low). The nearest resistance level sits at Rs 1,298.60 (200-day EMA) and Rs 1,425.10 (Supertrend). A sustained move above the nearest resistance would support the Global Health share price prediction 2027 base case, and this Global Health stock analysis uses daily candles only. Chart signals add context to the Global Health share price target without changing the earnings maths.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Global_Health_Shareholding_Pattern\"><\/span><strong>Global Health Shareholding Pattern<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Promoters hold 33.00% of Global Health as of Jun 2026, down from 33.01% in Jun 2025 across the last 5 quarters. FII holding is 9.46% (down from 11.54% in Jun 2025) and DII holding is 16.89% (up from 12.20% in Jun 2025), which puts combined institutional holding at 26.35%. Public shareholders own 40.65%. Shareholding data is one input for any Global Health stock forecast.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Risks_to_the_Global_Health_Share_Price_Target_for_2027\"><\/span><strong>Key Risks to the Global Health Share Price Target for 2027<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Earnings_and_Margin_Risk\"><\/span><strong>Earnings and Margin Risk<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Operating margin has ranged from 22.91% to 26.98% between FY22 and FY26, so a slip toward the lower end would trim the EPS estimate behind the Global Health stock forecast. Revenue was up 19.6% in FY26, and slower revenue growth would weigh on the profit path.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Size_and_Liquidity_Risk\"><\/span><strong>Size and Liquidity Risk<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Market capitalisation stands at Rs 34,310 crore. Investors should check daily traded volumes and order book depth on NSE before sizing a position, because price moves can be sharper when volumes thin out. Liquidity is a practical constraint on any Global Health stock price target.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Balance_Sheet_Risk\"><\/span><strong>Balance Sheet Risk<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Debt to equity of 0.30 means borrowings stand at about 30% of shareholder equity. A rise in borrowing costs or a jump in debt would weigh on profit and on the multiple behind the Global Health share price forecast.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Technical_Risk\"><\/span><strong>Technical Risk<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The daily indicators read bearish, so the targets above may need a technical turn before the price follows earnings. A daily close below Rs 956.00 (52-week low) would weaken the setup further.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>This Global Health stock analysis puts the share price target range for 2027 at Rs 1,490 to Rs 1,636, with a base case of Rs 1,554 against Rs 1,295.30 today. The inputs are a PE of 62.13 that sits in line with the industry average, EPS growth of 15.3% in FY26 and a daily technical setup that reads bearish. The next quarterly result will show which scenario is gaining ground. This analysis is educational, so consult a SEBI-registered advisor before acting on it.<\/p>\n<p style=\"margin-top:24px;\"><em>Download the <a href=\"https:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"https:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&#038;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track Global Health live price and get daily stock recommendations.<\/em><\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/p><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions_on_Global_Health_Share_Price_Prediction_2027\"><\/span><strong>Frequently Asked Questions on Global Health Share Price Prediction 2027<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_Global_Health_share_price_target_for_2027\"><\/span><strong>What is the Global Health share price target for 2027?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The Global Health share price forecast for 2027 has a conservative case of Rs 1,490, a base case of Rs 1,554 and a bull case of Rs 1,636. These are model scenarios based on reported EPS growth, and they are not guaranteed outcomes.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_Global_Health_share_price_today\"><\/span><strong>What is the Global Health share price today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Global Health trades at Rs 1,295.30 on NSE as of 9 October 2026, up 1.47% on the day. The 52-week range is Rs 956.00 to Rs 1,544.00.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Global_Health_a_good_stock_to_buy_for_2027\"><\/span><strong>Is Global Health a good stock to buy for 2027?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The data points in different directions: the PE of 62.13 is in line with the industry average, EPS grew 15.3% in FY26 and the daily technical setup reads bearish. This article does not constitute investment advice, so consult a SEBI-registered advisor before deciding.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Can_Global_Health_stock_reach_Rs_1636_in_2027\"><\/span><strong>Can Global Health stock reach Rs 1,636 in 2027?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Reaching Rs 1,636 needs EPS to rise 25.0% from Rs 20.54 and the PE multiple to re-rate toward the industry PE of 62.79, plus a daily close above Rs 1,298.60 (200-day EMA). This is a scenario, not a guarantee.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_support_and_resistance_levels_for_Global_Health\"><\/span><strong>What are the support and resistance levels for Global Health?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The nearest support levels are Rs 956.00 (52-week low), and the nearest resistance levels are Rs 1,298.60 (200-day EMA) and Rs 1,425.10 (Supertrend).<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_main_risks_for_Global_Health_stock_in_2027\"><\/span><strong>What are the main risks for Global Health stock in 2027?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The main risks to the Global Health share price forecast are a fall in operating margin from the 22.91% to 26.98% range seen since FY22, slower revenue growth after FY26 revenue was up 19.6%, and thin trading volumes. Debt to equity of 0.30 adds balance sheet sensitivity.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_is_the_Global_Health_target_price_for_2027_calculated\"><\/span><strong>How is the Global Health target price for 2027 calculated?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Each target scales the current price by assumed EPS growth at a constant PE multiple. The conservative case uses 15.0% growth, the base case 20.0% and the bull case 25.0%, all drawn from the company&#8217;s reported FY26 and 4-year EPS growth.<\/p>\n<p><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"What is the Global Health share price target for 2027?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The Global Health share price forecast for 2027 has a conservative case of Rs 1,490, a base case of Rs 1,554 and a bull case of Rs 1,636. These are model scenarios based on reported EPS growth, and they are not guaranteed outcomes.\"}},{\"@type\":\"Question\",\"name\":\"What is the Global Health share price today?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Global Health trades at Rs 1,295.30 on NSE as of 9 October 2026, up 1.47% on the day. The 52-week range is Rs 956.00 to Rs 1,544.00.\"}},{\"@type\":\"Question\",\"name\":\"Is Global Health a good stock to buy for 2027?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The data points in different directions: the PE of 62.13 is in line with the industry average, EPS grew 15.3% in FY26 and the daily technical setup reads bearish. This article does not constitute investment advice, so consult a SEBI-registered advisor before deciding.\"}},{\"@type\":\"Question\",\"name\":\"Can Global Health stock reach Rs 1,636 in 2027?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Reaching Rs 1,636 needs EPS to rise 25.0% from Rs 20.54 and the PE multiple to re-rate toward the industry PE of 62.79, plus a daily close above Rs 1,298.60 (200-day EMA). This is a scenario, not a guarantee.\"}},{\"@type\":\"Question\",\"name\":\"What are the support and resistance levels for Global Health?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The nearest support levels are Rs 956.00 (52-week low), and the nearest resistance levels are Rs 1,298.60 (200-day EMA) and Rs 1,425.10 (Supertrend).\"}},{\"@type\":\"Question\",\"name\":\"What are the main risks for Global Health stock in 2027?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The main risks to the Global Health share price forecast are a fall in operating margin from the 22.91% to 26.98% range seen since FY22, slower revenue growth after FY26 revenue was up 19.6%, and thin trading volumes. Debt to equity of 0.30 adds balance sheet sensitivity.\"}},{\"@type\":\"Question\",\"name\":\"How is the Global Health target price for 2027 calculated?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Each target scales the current price by assumed EPS growth at a constant PE multiple. The conservative case uses 15.0% growth, the base case 20.0% and the bull case 25.0%, all drawn from the company's reported FY26 and 4-year EPS growth.\"}}]}<\/script><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Global Health share price prediction 2027: base case Rs 1,554, bull case Rs 1,636 and a conservative case of Rs 1,490, built from reported EPS growth, valuation, technical levels and shareholding data.<\/p>\n","protected":false},"author":29,"featured_media":298532,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[24],"tags":[1154,1019],"class_list":["post-298533","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-market","tag-healthcare-stocks","tag-stock-market"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["298532"],"rank_math_title":["Global Health Share Price Prediction 2027: Target Rs 1,490-1,636"],"rank_math_description":["Global Health share price prediction 2027: conservative Rs 1,490, base Rs 1,554, bull Rs 1,636 vs current Rs 1,295. Valuation, financials, technicals and risks."],"rank_math_focus_keyword":["Global Health share price prediction 2027 | Density Target: 1.2-1.5%"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/10\/global-health-share-price-prediction-2027-scenario-targets-valuation-and.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/298533","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=298533"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/298533\/revisions"}],"predecessor-version":[{"id":298534,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/298533\/revisions\/298534"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/298532"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=298533"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=298533"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=298533"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}